A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).
Ann Oncol
; 28(11): 2901-2905, 2017 11 01.
Article
de En
| MEDLINE
| ID: mdl-27604385
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Ann Oncol
Sujet du journal:
NEOPLASIAS
Année:
2017
Type de document:
Article
Pays de publication:
Royaume-Uni